Expression of SLC30A10 and SLC23A3 Transporter mRNAs in Caco-2 Cells Correlates with an Increase in the Area of the Apical Membrane


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Drug bioavailability studies commonly employ in vitro barrier tissue models consisting of epithelial and endothelial cells. These experiments require that the cell barrier quality be assessed regularly, which is usually performed using various labeled substrates and/or evaluation of transepithelial (transendothelial) electrical resistance (TEER). This technique provides information on the integrity of the monolayer, but not on differentiation-induced changes in the cell morphology. The present work shows that impedance spectroscopy can be applied to monitor both the integrity of the monolayer and the morphological changes of Caco-2 cells. The growth kinetics of the apical membrane was determined by calculating the electrical capacitance of the cell monolayer. In the course of differentiation, the most pronounced changes in the expression levels were observed for the mRNAs that encode SLC30A10 and SLC23A3 transporters. Their increase correlated with an increase in the apical membrane area, indicating that SLC30A10 and SLC23A3 mRNA levels assessed by qRT-PCR may be employed as cell differentiation biomarkers in Caco-2 models.

Sobre autores

S. Nikulin

Bioclinicum Research and Development Center; Moscow Institute of Physics and Technology (State University)

Autor responsável pela correspondência
Email: s.nikulin@bioclinicum.com
Rússia, Moscow, 115088; Dolgoprudny, Moscow oblast, 141701

E. Knyazev

Bioclinicum Research and Development Center

Email: s.nikulin@bioclinicum.com
Rússia, Moscow, 115088

A. Poloznikov

Bioclinicum Research and Development Center

Email: s.nikulin@bioclinicum.com
Rússia, Moscow, 115088

S. Shilin

Bioclinicum Research and Development Center

Email: s.nikulin@bioclinicum.com
Rússia, Moscow, 115088

I. Gazizov

Bioclinicum Research and Development Center

Email: s.nikulin@bioclinicum.com
Rússia, Moscow, 115088

G. Zakharova

Bioclinicum Research and Development Center

Email: s.nikulin@bioclinicum.com
Rússia, Moscow, 115088

T. Gerasimenko

Bioclinicum Research and Development Center

Email: s.nikulin@bioclinicum.com
Rússia, Moscow, 115088

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Pleiades Publishing, Inc., 2018